🇺🇸 FDA
Patent

US 6011139

Hybridomas and monoclonal antibodies that specifically bind to glutamic acid decarboxylase peptides

expired A61KA61K38/00A61K38/51

Quick answer

US patent 6011139 (Hybridomas and monoclonal antibodies that specifically bind to glutamic acid decarboxylase peptides) held by The Regents of the University of California expires Mon Dec 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/00, A61K38/51, A61K39/00, A61P